The Second Multicenter Hemophilia Cohort Study

Sponsor
National Cancer Institute (NCI) (NIH)
Overall Status
Completed
CT.gov ID
NCT00341705
Collaborator
Multicenter Hemophilia Cohort Study (Other)
2,565
48
143.2
53.4
0.4

Study Details

Study Description

Brief Summary

The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majority will have been infected with HCV, and approximately 1/3 will have been infected with human immunodeficiency virus (HIV). Primary objectives are to quantify the rates of liver decompensation, hepatocellular carcinoma, and non-Hodgkin lymphoma and to evaluate candidate clinical, genetic, virologic, serologic and immunologic markers that are likely to be on the causal pathway for these conditions. Candidate clinical and laboratory markers will be examined longitudinally to define changes over time and their relationships to one another. Collaborative studies will focus on genome scanning and evaluation of candidate genetic loci for susceptibility or resistance to HCV and HIV infections or to the diseases that result from these infections. Additional studies will identify response and complication rates of various anti-HCV and anti-HIV regimens in the setting of comprehensive clinical care of persons with hemophilia.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The Second Multicenter Hemophilia Cohort Study (MHCS-II) will evaluate and prospectively follow approximately 4500 persons with hemophilia who were exposed to hepatitis C virus (HCV). The vast majority will have been infected with HCV, and approximately 1/3 will have been infected with human immunodeficiency virus (HIV). Primary objectives are to quantify the rates of liver decompensation, hepatocellular carcinoma, and non-Hodgkin lymphoma and to evaluate candidate clinical, genetic, virologic, serologic and immunologic markers that are likely to be on the causal pathway for these conditions. Candidate clinical and laboratory markers will be examined longitudinally to define changes over time and their relationships to one another. Collaborative studies will focus on genome scanning and evaluation of candidate genetic loci for susceptibility or resistance to HCV and HIV infections or to the diseases that result from these infections. Additional studies will identify response and complication rates of various anti-HCV and anti-HIV regimens in the setting of comprehensive clinical care of persons with hemophilia.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    2565 participants
    Official Title:
    The Second Multicenter Hemophilia Cohort Study
    Study Start Date :
    Apr 27, 2001
    Study Completion Date :
    Apr 2, 2013

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      13 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      • INCLUSION CRITERIA:

      Must be registered patient with an inherited coagulation disorder at a participating MHCS-II center. Disorders include hemophilia A or B (congenital factor VIII or IX deficiency), deficiencies in other factors such as V or XI, and vonWillebrand's disease. (Unless noted otherwise, all of the disorders will collectively be referred to as hemophilia .) All such hemophilia and vonWillebrand s disease patients are to be recruited as study participants.

      Since January 1, 1993, must have had at least one positive result on a licensed assay for HCV antibodies, HIV antibodies, or HIV RNA.

      Must be at least 13 years of age at enrollment.

      Must provide signed informed consent or, for minors, signed assent plus signed informed consent from the parent or guardian.

      EXCLUSION CRITERIA:

      Is not a patient with an inherited coagulation disorder.

      Does not have a positive test for HCV antibodies, HIV antibodies, or HIV RNA on a licensed assay performed since January 1, 1993.

      Is less than 13 years of age.

      Lacks informed consent/assent.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 University of Arizona Tucson Arizona United States 85724
      2 University of California, Davis Davis California United States 95616
      3 Children's Hospital of Orange County Orange California United States 92613
      4 University of California, San Francisco San Francisco California United States 94143
      5 University of Colorado Denver Colorado United States 80220-3706
      6 Christiana Hospital Wilmington Delaware United States
      7 Georgetown University Washington District of Columbia United States 20007-2197
      8 Childrens National Medical Center Washington District of Columbia United States
      9 Emory University Atlanta Georgia United States 30322-1102
      10 University of Illinois Chicago Illinois United States 60612
      11 Childrens Memorial Hospital, Chicago Chicago Illinois United States 60614-3394
      12 St. Vincent's Hospital Indianapolis Indiana United States
      13 Tulane University New Orleans Louisiana United States 70112-2699
      14 Wayne State University Hutzel Hospital Detroit Michigan United States 48201
      15 University of Minnesota Minneapolis Minnesota United States 55415
      16 University of Mississippi Jackson Mississippi United States 39216
      17 St. Louis University Saint Louis Missouri United States 63104
      18 University of New Mexico Albuquerque New Mexico United States 87131
      19 University of Buffalo Buffalo New York United States
      20 North Shore Long Island Jewish Health System Lake Success New York United States 11042
      21 Cornell University New York New York United States 10021-4872
      22 Mt. Sinai Medical Center New York New York United States 10029-0574
      23 University of North Carolina Chapel Hill North Carolina United States 27599-7030
      24 Wake Forest University Winston-Salem North Carolina United States 27103
      25 Childrens Hospital, Cinncinati Cincinnati Ohio United States 45229-3039
      26 University of Cincinnati Cincinnati Ohio United States 45267
      27 Ohio State University Columbus Ohio United States 43210-1240
      28 Wright State University Dayton Ohio United States 45435
      29 University of Oklahoma Oklahoma City Oklahoma United States
      30 Milton Hershey Medical Center Hershey Pennsylvania United States 17033
      31 University of Pennsylvania Philadelphia Pennsylvania United States 19104-6056
      32 Thomas Jefferson University Philadelphia Pennsylvania United States 19107-6541
      33 Palmentto Health Alliance Columbia South Carolina United States 29202
      34 University of Tennessee Memphis Tennessee United States 38103
      35 Vanderbilt University Nashville Tennessee United States 37232
      36 University of Texas, Houston Houston Texas United States 77030
      37 University of Texas, San Antonio San Antonio Texas United States
      38 University of Utah Salt Lake City Utah United States 84112
      39 Childrens Hospital of Wisconsin Milwaukee Wisconsin United States
      40 Hospital Brigadeiro Sao Paulo Brazil
      41 University of Sao Paulo Sao Paulo Brazil
      42 South East Health Care Corporation New Brunswick Canada
      43 Hospices Civils de Lyon Lyons France
      44 University of Bonn Bonn Germany
      45 Laikon General Hospital of Athens Athens Greece
      46 University of Florence Florence Italy
      47 University de Milano Milan Italy
      48 Karolinska Institute St. Gorans Hospital Stockholm Sweden

      Sponsors and Collaborators

      • National Cancer Institute (NCI)
      • Multicenter Hemophilia Cohort Study

      Investigators

      • Principal Investigator: James J Goedert, M.D., National Cancer Institute (NCI)

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00341705
      Other Study ID Numbers:
      • 999901170
      • 01-C-N170
      First Posted:
      Jun 21, 2006
      Last Update Posted:
      Dec 17, 2019
      Last Verified:
      Apr 2, 2013
      Keywords provided by , ,
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Dec 17, 2019